federal_register: 2022-22744

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2022-22744 Animal Generic Drug User Fee Act; Public Meeting; Request for Comments; Extension of Comment Period Notice The Food and Drug Administration (FDA, the Agency, or we) is extending the comment period for the notice announcing a public meeting and requesting comments that appeared in the Federal Register of September 30, 2022. In that notice, FDA announced a public meeting to discuss the proposed recommendations for the reauthorization of the Animal Generic Drug User Fee Act (AGDUFA IV) for fiscal years 2024 through 2028 and that the comment period would be open until November 9, 2022. FDA is taking this action due to a delay in the posting of the AGDUFA IV Performance Goals and Procedures Letter. This extension will provide the public 30 days to comment as required. 2022-10-20 2022 10 https://www.federalregister.gov/documents/2022/10/20/2022-22744/animal-generic-drug-user-fee-act-public-meeting-request-for-comments-extension-of-comment-period https://www.govinfo.gov/content/pkg/FR-2022-10-20/pdf/2022-22744.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA, the Agency, or we) is extending the comment period for the notice announcing a public meeting and requesting comments that appeared in the Federal Register of September 30, 2022. In that notice, FDA announced a...  

Links from other tables